DEVELOPMENT AND TECHNOLOGY OF MRNA VACCINES AND THERAPEUTICS BEYOND COVID-19
Jayaprakash Sagayaraj, Monisha and S, Vishnupriya and K, Nithyasri (2026) DEVELOPMENT AND TECHNOLOGY OF MRNA VACCINES AND THERAPEUTICS BEYOND COVID-19. In: International Conference on Scientific Research and Revolution ICSRR 2026.
SRR's ICSRR 2026 Proceedings-1 (1)-36.pdf
Download (658kB)
Abstract
This study is based on the application of mRNA vaccines for the treatment
of various infectious diseases and different cancer types. An mRNA
vaccine is a new type of vaccine that introduces cells into the human body
that produce harmless protein to trigger the immune system to develop
immunity-producing antibodies against antigens. These vaccines were
developed after the global outbreak of COVID-19. This significantly helped
the scientists to invent vaccines in a short period of time compared to the
traditional vaccines. The main role is to reduce the death rate by
controlling the spread of disease. In the case of cancer, mRNA vaccines
help the immune system to recognize and destroy the cancer cells by
producing the tumor-specific antigens. In order to create targeted mRNA
technology, including its applications in vaccines, immunotherapies,
protein replacement therapy, and genome editing as well as its
distribution to particular cell types and organs.
| Item Type: | Conference or Workshop Item (Poster) |
|---|---|
| Subjects: | Pharmaceutics > Introduction To Dosage Forms |
| Domains: | Pharmaceutics |
| Depositing User: | user 12 12 |
| Date Deposited: | 11 Jun 2026 08:59 |
| Last Modified: | 11 Jun 2026 08:59 |
| URI: | https://ir.vistas.ac.in/id/eprint/21195 |
